Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew J During

Showing results (31-40 of 116) with videos related to

Pageof 12
Sort By:
Journal of Neurophysiology|October 29, 2010
Potentiation of synaptic AMPA receptors induced by the deletion of NMDA receptors requires the GluA2 subunitWei Lu, John A Gray, Adam J Granger, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|April 10, 2008
HSP70 and constitutively active HSF1 mediate protection against CDCrel-1-mediated toxicityAlisha E Jung, Helen L Fitzsimons, Ross J Bland, et al.
Neuron|September 29, 2011
Distinct modes of AMPA receptor suppression at developing synapses by GluN2A and GluN2B: single-cell NMDA receptor subunit deletion in vivoJohn A Gray, Yun Shi, Hiroshi Usui, et al.
Molecular and Cellular Neurosciences|July 26, 2008
Activity-dependent volume transmission by transgene NPY attenuates glutamate release and LTP in the subiculumAndreas T Sørensen, Irene Kanter-Schlifke, En-Ju D Lin, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|April 27, 2005
Restoration of aspartoacylase activity in CNS neurons does not ameliorate motor deficits and demyelination in a model of Canavan diseaseMatthias Klugmann, Claudia B Leichtlein, C Wymond Symes, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 4, 2004
AAV-mediated gene delivery of BDNF or GDNF is neuroprotective in a model of Huntington diseaseAdrian P Kells, Dahna M Fong, Mike Dragunow, et al.
The European Journal of Neuroscience|November 19, 2003
Recombinant AAV-mediated expression of galanin in rat hippocampus suppresses seizure developmentEn-Ju D Lin, Cristina Richichi, Deborah Young, et al.
Biological Psychiatry|October 24, 2003
Disulfiram facilitates the development and expression of locomotor sensitization to cocaine in ratsColin N Haile, Matthew J During, Peter I Jatlow, et al.
Brain Research|September 18, 2004
A role for dopamine in feeding responses produced by orexigenic agentsThomas S Hnasko, Mark S Szczypka, William A Alaynick, et al.
Nature Medicine|March 10, 2009
Molecular therapy of obesity and diabetes by a physiological autoregulatory approachLei Cao, En-Ju D Lin, Michael C Cahill, et al.
Pageof 12

Showing results (31-40 of 116) with videos related to

Sort By:
Pageof 12
Journal of Neurophysiology|October 29, 2010
Potentiation of synaptic AMPA receptors induced by the deletion of NMDA receptors requires the GluA2 subunitWei Lu, John A Gray, Adam J Granger, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|April 10, 2008
HSP70 and constitutively active HSF1 mediate protection against CDCrel-1-mediated toxicityAlisha E Jung, Helen L Fitzsimons, Ross J Bland, et al.
Neuron|September 29, 2011
Distinct modes of AMPA receptor suppression at developing synapses by GluN2A and GluN2B: single-cell NMDA receptor subunit deletion in vivoJohn A Gray, Yun Shi, Hiroshi Usui, et al.
Molecular and Cellular Neurosciences|July 26, 2008
Activity-dependent volume transmission by transgene NPY attenuates glutamate release and LTP in the subiculumAndreas T Sørensen, Irene Kanter-Schlifke, En-Ju D Lin, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|April 27, 2005
Restoration of aspartoacylase activity in CNS neurons does not ameliorate motor deficits and demyelination in a model of Canavan diseaseMatthias Klugmann, Claudia B Leichtlein, C Wymond Symes, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 4, 2004
AAV-mediated gene delivery of BDNF or GDNF is neuroprotective in a model of Huntington diseaseAdrian P Kells, Dahna M Fong, Mike Dragunow, et al.
The European Journal of Neuroscience|November 19, 2003
Recombinant AAV-mediated expression of galanin in rat hippocampus suppresses seizure developmentEn-Ju D Lin, Cristina Richichi, Deborah Young, et al.
Biological Psychiatry|October 24, 2003
Disulfiram facilitates the development and expression of locomotor sensitization to cocaine in ratsColin N Haile, Matthew J During, Peter I Jatlow, et al.
Brain Research|September 18, 2004
A role for dopamine in feeding responses produced by orexigenic agentsThomas S Hnasko, Mark S Szczypka, William A Alaynick, et al.
Nature Medicine|March 10, 2009
Molecular therapy of obesity and diabetes by a physiological autoregulatory approachLei Cao, En-Ju D Lin, Michael C Cahill, et al.
Pageof 12